Table 3 Summary of the current relevant literature and comparison with the present results
Indications no, (%) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Study | No. patients | No. EUS | Time frame (No. years) | Age (y), range (mean) | Pancreatobiliary | Rectum | Stomach | Esophagus | Duodenum | Other | EUS-FNA no, (%) |
Roseau et al. 1998 [14] | 18 | 23 | 7 | 4–16 (12) | 8(34.8) | 6(26.1) | 6(26.1) | 1(4.3) | 1(4.3) | 1(4.3) | 0 |
Varadarajulu et al. 2005 [15] | 14 | 15 | 3 | 5–17 (13) | 15 (100) | 0 | 0 | 0 | 0 | 0 | 3 (20) |
Cohen et al. 2008 [3] | 32 | 32 | 6 | 1.5–18 (12) | 19 (59.4) | 2 (6.3) | 2 (6.3) | 8 (25) | 1 (3.1) | 0 | 7 (21.9) |
Bjerring et al. 2008 [16] | 18 | 18 | 16 | 0.5–15 (12) | 11 (61.1) | 0 | 3 (16.7) | 0 | 0 | 4 (22.2) | 0 |
Attila et al. 2009 [13] | 38 | 40 | 7 | 3–17 (13.5) | 25 (62.5) | 1 (2.5) | 6 (15) | 1 (2.5) | 0 | 7 (17.5) | 12 (30) |
Al-Rashdan et al. 2010 [12] | 56 | 58 | 8 | 4–18 (16) | 42 (72.4) | 4 (6.9) | 1 (1.7) | 1 (1.7) | 0 | 10 (17.2) | 15 (25.9) |
Rosen et al. 2010 [17] | 25 | 42 | 5 | NA (14) | 0 | 42 (100) | 0 | 0 | 0 | 0 | 0 |
Scheers et al. 2015 [1] | 48 | 52 | 14 | 2–17 (12) | 52 (100) | 0 | 0 | 0 | 0 | 0 | 12 (23.1) |
Gordon et al. 2015 [11] | 43 | 51 | 6 | 4–18 (14.5) | 34 (66.7) | 1 (1.9) | 6 (11.8) | 0 | 0 | 10 (19.6) | 13 (25.5) |
Mahajan et al. 2016 [8] | 121 | 125 | 8 | 3–18 (15.2) | 118 (94.4) | 0 | 2 (1.6) | 0 | 0 | 5 (4) | 7 (5.6) |
TOTAL (sum or weighted mean) | 413 | 456 | 8 | 0.5–18 (14) | 324 (71.1) | 56 (12.3) | 26 (5.7) | 11 (2.4) | 2 (0.4) | 37 (8.1) | 69 (15.1) |
Present study | 40 | 47 | 6 | 3–18 (15.1) | 28 (59.6) | 15 (31.9) | 2 (4.3) | 0 | 2 (4.3) | 0 | 3 (6.4) |